Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) insider Geus Aart De sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $445.55, for a total transaction of $11,138,750.00. Following the transaction, the insider directly owned 120,421 shares of the company’s stock, valued at approximately $53,653,576.55. This trade represents a 17.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Synopsys Price Performance
SNPS stock traded down $3.02 on Monday, reaching $439.59. The company had a trading volume of 1,680,894 shares, compared to its average volume of 1,998,091. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $615.79. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The company’s fifty day moving average is $416.64 and its 200 day moving average is $440.14. The company has a market cap of $84.24 billion, a P/E ratio of 77.67, a PEG ratio of 2.42 and a beta of 1.23.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter last year, the business posted $3.39 earnings per share. Synopsys’s revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, research analysts forecast that Synopsys, Inc. will post 11.03 earnings per share for the current year.
Institutional Investors Weigh In On Synopsys
Analyst Ratings Changes
A number of brokerages recently issued reports on SNPS. Benchmark restated a “buy” rating and set a $570.00 target price on shares of Synopsys in a research report on Thursday. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a research report on Wednesday, August 19th. Stifel Nicolaus lifted their price target on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research note on Thursday. Finally, UBS Group set a $570.00 price objective on shares of Synopsys in a report on Thursday. Twelve analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $561.28.
View Our Latest Stock Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
